Patent details

EP3334432 Title: CERDULATINIB FOR TREATING MYELOMA

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
EP3334432
WO Application Number:
US2016046862
Type:
European Patent Granted for NL
Status:
Deemed not to be granted according to art. 52.4a or 52.6 ROW
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP16835995.8
WO Publication Number:
WO2017027829
EPO Publication Language:
English
SPC Number:
First Applicant Residence Country:
United States of America (US)
Publications:

Dates

Filing date:
12/08/2016
Grant date:
23/02/2022
EP Publication Date:
20/06/2018
WO Publication Date:
16/02/2017
Claims Translations Received Date:
Claims Translation B1 Received Date:
Claims Translation B2 Received Date:
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
23/02/2022
EP B1 Publication Date:
23/02/2022
EP B2 Publication Date:
EP B3 Publication Date:
Description Translation B1 Received Date:
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
11/08/2036
Lapsed By Expiration Date:
Revocation Date:
Invalidity Date:
23/02/2022
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:

Applicant/holder

From:
23/02/2022
 
 

 

Name:
Portola Pharmaceuticals, Inc.
Address:
270 East Grand Avenue Suite 22, South San Francisco, California 94080, United States of America (US)

Inventor

1

Name:
COFFEY, Gregory
Address:
South San Francisco, California 94080, United States of America (US)

2

Name:
FENG, Jiajia
Address:
South San Francisco, California 94080, United States of America (US)

Priority

1

Priority Patent Number:
201662342711 P
Priority Date:
27/05/2016
Priority Country:
United States of America (US)

2

Priority Patent Number:
201562204400 P
Priority Date:
12/08/2015
Priority Country:
United States of America (US)

Classification

IPC or IDT classification:
A61K 31/506; A61K 31/551; C07D 279/12; A61K 45/06; A61P 35/02;

Publication

Bulletin

1

Bulletin Heading:
VRV
Journal edition number:
26/22
Publication date:
29/06/2022
Description:
Lapse or annulment

2

Bulletin Heading:
EP2
Journal edition number:
08/22
Publication date:
23/02/2022
Description:
European patents granted for the Netherlands

European Patent Bulletin

Issue number:
202208
Publication date:
23/02/2022
Description:
Grant (B1)

Annual Fee

Annual Fee(s) Due Date:
Annual Fee Number:
Last Annual Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Document Description Number of pages File Type